Vyome Holdings, Inc (HIND): Operating Cash Flow
-$3.75M
Year ended 2025-12-31
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$3.75M | n/m | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | -$614.1K | n/m | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | -$16.96M | n/m | 2025-04-04, From 2023-01-01 |
| 2022-12-31 | -$21.90M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$15.38M | n/m | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | -$8.55M | n/c | 2022-04-08, From 2020-01-01 |
| 2019-12-31 | -$22.87M | n/m | 2021-03-12, From 2019-01-01 |
| 2018-12-31 | -$29.43M | n/m | 2020-02-27, From 2018-01-01 |
| 2017-12-31 | -$30.62M | n/m | 2019-02-22, From 2017-01-01 |
| 2016-12-31 | -$19.37M | n/m | 2018-03-05, From 2016-01-01 |
| 2015-12-31 | -$11.39M | n/m | 2018-03-05, From 2015-01-01 |
| 2014-12-31 | -$9.91M | n/a | 2017-02-23, From 2014-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | 2025-12-31 | -$3.75M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | -$14.82M | n/m |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$3.33M | n/m |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | -$2.99M | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$8.95M | n/m |
| Medicinova Inc (MNOV) | 2025-12-31 | -$9.81M | n/m |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | -$13.38M | n/m |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$383.6K | n/m |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | -$30.97M | n/m |
Compare HIND, ALLR, PVCT, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗